Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome. (26th March 2019) - Engel, S; Luessi, F; Henning, B; Bittner, S; Loquai, C; Zipp, F